Literature DB >> 23247742

Metastatic lymph node ratio as a prognostic factor after laparoscopic total mesorectal excision for extraperitoneal rectal cancer.

Marco Ettore Allaix1, Alberto Arezzo, Paola Cassoni, Massimiliano Mistrangelo, Giuseppe Giraudo, Mario Morino.   

Abstract

BACKGROUND: The lymph node ratio (LNR; number of positive nodes divided by total nodes harvested) has been demonstrated to be a prognostic factor in colon cancer, but its role in extraperitoneal rectal cancer is still debated; furthermore, no data are available on laparoscopic rectal resection. The aim of this study was to evaluate the prognostic impact of LNR on long-term outcomes after laparoscopic total mesorectal excision (LTME) for extraperitoneal cancer in consecutive patients with a 5-year minimum follow-up.
METHODS: This study is a prospective analysis of consecutive patients who underwent LTME for adenocarcinoma of the extraperitoneal rectum.
RESULTS: LTME was performed in 158 patients. The median number of LN harvested was 12 (range = 3-25). The proportion of specimens with fewer than 12 examined LN was significantly higher in patients who had neoadjuvant chemoradiotherapy (p < 0.001). During a median follow-up period of 122 months, the local recurrence rate was 8 %. At univariate analysis, disease-free survival and overall survival significantly decreased with increasing LNR (p < 0.001). Multivariate analysis showed that the distal margin ≤ 1 cm was the only independent predictor of local recurrence (p = 0.028). LNR (cutoff value = 0.25) and lymphovascular invasion were significant prognostic factors for both disease-free (p = 0.015 and p = 0.046, respectively) and overall survival (p = 0.031 and p = 0.040, respectively). Even in the subgroup of patients in whom fewer than 12 LN were examined, LNR confirmed its prognostic role, with a statistical trend toward worse disease-free survival and overall survival.
CONCLUSION: Metastatic LNR is an independent prognostic factor for disease-free survival and overall survival after LTME for extraperitoneal rectal cancer.

Entities:  

Mesh:

Year:  2012        PMID: 23247742     DOI: 10.1007/s00464-012-2694-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  50 in total

1.  The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma.

Authors:  F Bretagnol; B Lelong; C Laurent; V Moutardier; A Rullier; G Monges; J-R Delpero; E Rullier
Journal:  Surg Endosc       Date:  2005-05-12       Impact factor: 4.584

2.  Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis.

Authors:  Nancy N Baxter; Arden M Morris; David A Rothenberger; Joel E Tepper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-02-01       Impact factor: 7.038

3.  Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered.

Authors:  N S Goldstein; W Sanford; M Coffey; L J Layfield
Journal:  Am J Clin Pathol       Date:  1996-08       Impact factor: 2.493

4.  Number of nodes examined and staging accuracy in colorectal carcinoma.

Authors:  J H Wong; R Severino; M B Honnebier; P Tom; T S Namiki
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

5.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

6.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

7.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Authors:  Robert Rosenberg; Jan Friederichs; Tibor Schuster; Ralf Gertler; Matthias Maak; Karen Becker; Anne Grebner; Kurt Ulm; Heinz Höfler; Hjalmar Nekarda; Jörg-Rüdiger Siewert
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

8.  The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.

Authors:  Frédérique Peschaud; Peschaud Frédérique; Stéphane Benoist; Benoist Stéphane; Catherine Julié; Julié Catherine; Alain Beauchet; Beauchet Alain; Christophe Penna; Penna Christophe; Philippe Rougier; Rougier Philippe; Bernard Nordlinger
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

9.  Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial.

Authors:  Simon S M Ng; Ka Lau Leung; Janet F Y Lee; Raymond Y C Yiu; Jimmy C M Li; Anthony Y B Teoh; Wing Wa Leung
Journal:  Ann Surg Oncol       Date:  2008-04-05       Impact factor: 5.344

10.  Total mesorectal excision (TME) with laparoscopic approach: 226 consecutive cases.

Authors:  Carlo Staudacher; Saverio Di Palo; Andrea Tamburini; Andrea Vignali; Elena Orsenigo
Journal:  Surg Oncol       Date:  2007-11-28       Impact factor: 3.279

View more
  6 in total

1.  Prognostic value of lymph node ratio in patients with pathological N1 non-small cell lung cancer: a systematic review with meta-analysis.

Authors:  Qian Li; Ping Zhan; Dongmei Yuan; Tangfeng Lv; Alexander Sasha Krupnick; Antonio Passaro; Alessandro Brunelli; Matthew P Smeltzer; Raymond U Osarogiagbon; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2016-06

2.  10-Year Oncologic Outcomes After Laparoscopic or Open Total Mesorectal Excision for Rectal Cancer.

Authors:  Marco E Allaix; Giuseppe Giraudo; Alessia Ferrarese; Alberto Arezzo; Fabrizio Rebecchi; Mario Morino
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

3.  Laparoscopic versus open resection for colon cancer: 10-year outcomes of a prospective clinical trial.

Authors:  Marco E Allaix; Giuseppe Giraudo; Massimiliano Mistrangelo; Alberto Arezzo; Mario Morino
Journal:  Surg Endosc       Date:  2014-08-09       Impact factor: 4.584

4.  Prognostic value of metastatic N1 lymph node ratio and angiolymphatic invasion in patients with pathologic stage IIA non-small cell lung cancer.

Authors:  Ching-Feng Wu; Ching-Yang Wu; Jui-Ying Fu; Chi-Wei Wang; Yun-Hen Liu; Ming-Ju Hsieh; Yi-Cheng Wu
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

5.  Clinical significance of the metastatic lymph-node ratio in rectal cancer.

Authors:  Hyoung Chul Park
Journal:  Ann Coloproctol       Date:  2013-06

6.  Lymph Node Ratio as a Prognostic Marker in Rectal Cancer Survival: A Systematic Review and Meta-Analysis.

Authors:  Uday Karjol; Pavan Jonnada; Ajay Chandranath; Sushma Cherukuru
Journal:  Cureus       Date:  2020-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.